APO Research, Inc.

APO RESEARCH · REPORT

Poloxamer

Selected research

Market Analysis & Forecast

Global Poloxamer Market Analysis and Forecast 2026-2032

Market perspective

The global Poloxamer market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Poloxamer's global sales reached XX (Tons) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned BASF as the global sales leader, a title it has maintained for several consecutive years. Notably, BASF's performance in primary markets is also remarkable. In the Chinese market, sales were XX (Tons), a change of XX% from the previous year. In Europe, sales were XX (Tons), showing a year-on-year of XX%. In the US, sales were XX (Tons), a year-on-year change of XX%.

The major global manufacturers in the Poloxamer market include BASF, ADEKA, Croda, Nanjing Well, Hubei Hengshuo, Solvay and Merck KGaA, etc. In 2025, the top three vendors accounted for approximately % of the revenue.

Read the full market overview

In terms of production side, this report researches the Poloxamer production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.

In terms of consumption side, this report focuses on the sales of Poloxamer by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.

This report presents an overview of global market for Poloxamer, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Poloxamer, also provides the consumption of main regions and countries. Of the upcoming market potential for Poloxamer, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Poloxamer sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Poloxamer market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Poloxamer sales, projected growth trends, production technology, application and end-user industry.

Poloxamer Segment by Company

BASF

ADEKA

Croda

Nanjing Well

Hubei Hengshuo

Solvay

Merck KGaA

Poloxamer Segment by Type

Poloxamer 124

Poloxamer 184

Poloxamer 188

Poloxamer 338

Poloxamer 407

Others

Poloxamer Segment by Application

Cosmetics Industrial

Biologics

Pharmaceutical Industrial

Others

Poloxamer Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Poloxamer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Poloxamer and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Poloxamer.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Poloxamer production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of Poloxamer in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of Poloxamer manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Poloxamer sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Poloxamer Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Poloxamer 124 Major Manufacturers Table 3. Poloxamer 184 Major Manufacturers Table 4. Poloxamer 188 Major Manufacturers Table 5. Poloxamer 338 Major Manufacturers Table 6. Poloxamer 407 Major Manufacturers Table 7. Others Major Manufacturers Table 8. Global Poloxamer Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Cosmetics Industrial Major Manufacturers Table 10. Biologics Major Manufacturers Table 11. Pharmaceutical Industrial Major Manufacturers Table 12. Others Major Manufacturers Table 13. Poloxamer Industry Trends Table 14. Poloxamer Industry Drivers Table 15. Poloxamer Industry Opportunities and Challenges Table 16. Poloxamer Industry Restraints Table 17. Global Poloxamer Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 18. Global Poloxamer Production by Region (2021-2026) & (Tons) Table 19. Global Poloxamer Production by Region (2027-2032) & (Tons) Table 20. Global Poloxamer Production Market Share by Region (2021-2026) Table 21. Global Poloxamer Production Market Share by Region (2027-2032) Table 22. Global Poloxamer Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 23. Global Poloxamer Revenue by Region (2021-2026) & (US$ Million) Table 24. Global Poloxamer Revenue by Region (2027-2032) & (US$ Million) Table 25. Global Poloxamer Revenue Market Share by Region (2021-2026) Table 26. Global Poloxamer Revenue Market Share by Region (2027-2032) Table 27. Global Poloxamer Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 28. Global Poloxamer Sales by Region (2021-2026) & (Tons) Table 29. Global Poloxamer Sales by Region (2027-2032) & (Tons) Table 30. Global Poloxamer Sales Market Share by Region (2021-2026) Table 31. Global Poloxamer Sales Market Share by Region (2027-2032) Table 32. Global Poloxamer Revenue by Manufacturers (US$ Million) & (2021-2026) Table 33. Global Poloxamer Revenue Market Share by Manufacturers (2021-2026) Table 34. Global Poloxamer Sales by Manufacturers (US$ Million) & (2021-2026) Table 35. Global Poloxamer Sales Market Share by Manufacturers (2021-2026) Table 36. Global Poloxamer Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 37. Global Poloxamer Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 38. Global Poloxamer Key Manufacturers Manufacturing Sites & Headquarters Table 39. Global Poloxamer Manufacturers, Product Type & Application Table 40. Global Poloxamer Manufacturers Commercialization Time Table 41. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 42. Global Poloxamer by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 43. Global Poloxamer Revenue by Type (2021-2026) & (US$ Million) Table 44. Global Poloxamer Revenue by Type (2027-2032) & (US$ Million) Table 45. Global Poloxamer Revenue Market Share by Type (2021-2026) Table 46. Global Poloxamer Revenue Market Share by Type (2027-2032) Table 47. Global Poloxamer Sales by Type (2021-2026) & (Tons) Table 48. Global Poloxamer Sales by Type (2027-2032) & (Tons) Table 49. Global Poloxamer Sales Market Share by Type (2021-2026) Table 50. Global Poloxamer Sales Market Share by Type (2027-2032) Table 51. Global Poloxamer Price by Type (2021-2026) & (US$/Ton) Table 52. Global Poloxamer Price by Type (2027-2032) & (US$/Ton) Table 53. Global Poloxamer Revenue by Application (2021-2026) & (US$ Million) Table 54. Global Poloxamer Revenue by Application (2027-2032) & (US$ Million) Table 55. Global Poloxamer Revenue Market Share by Application (2021-2026) Table 56. Global Poloxamer Revenue Market Share by Application (2027-2032) Table 57. Global Poloxamer Sales by Application (2021-2026) & (Tons) Table 58. Global Poloxamer Sales by Application (2027-2032) & (Tons) Table 59. Global Poloxamer Sales Market Share by Application (2021-2026) Table 60. Global Poloxamer Sales Market Share by Application (2027-2032) Table 61. Global Poloxamer Price by Application (2021-2026) & (US$/Ton) Table 62. Global Poloxamer Price by Application (2027-2032) & (US$/Ton) Table 63. BASF Company Information Table 64. BASF Business Overview Table 65. BASF Poloxamer Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. BASF Poloxamer Product Portfolio Table 67. BASF Recent Development Table 68. ADEKA Company Information Table 69. ADEKA Business Overview Table 70. ADEKA Poloxamer Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. ADEKA Poloxamer Product Portfolio Table 72. ADEKA Recent Development Table 73. Croda Company Information Table 74. Croda Business Overview Table 75. Croda Poloxamer Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Croda Poloxamer Product Portfolio Table 77. Croda Recent Development Table 78. Nanjing Well Company Information Table 79. Nanjing Well Business Overview Table 80. Nanjing Well Poloxamer Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Nanjing Well Poloxamer Product Portfolio Table 82. Nanjing Well Recent Development Table 83. Hubei Hengshuo Company Information Table 84. Hubei Hengshuo Business Overview Table 85. Hubei Hengshuo Poloxamer Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Hubei Hengshuo Poloxamer Product Portfolio Table 87. Hubei Hengshuo Recent Development Table 88. Solvay Company Information Table 89. Solvay Business Overview Table 90. Solvay Poloxamer Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Solvay Poloxamer Product Portfolio Table 92. Solvay Recent Development Table 93. Merck KGaA Company Information Table 94. Merck KGaA Business Overview Table 95. Merck KGaA Poloxamer Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Merck KGaA Poloxamer Product Portfolio Table 97. Merck KGaA Recent Development Table 98. North America Poloxamer Revenue by Type (2021-2026) & (US$ Million) Table 99. North America Poloxamer Revenue by Type (2027-2032) & (US$ Million) Table 100. North America Poloxamer Sales by Type (2021-2026) & (Tons) Table 101. North America Poloxamer Sales by Type (2027-2032) & (Tons) Table 102. North America Poloxamer Sales Price by Type (2021-2026) & (US$/Ton) Table 103. North America Poloxamer Sales Price by Type (2027-2032) & (US$/Ton) Table 104. North America Poloxamer Revenue by Application (2021-2026) & (US$ Million) Table 105. North America Poloxamer Revenue by Application (2027-2032) & (US$ Million) Table 106. North America Poloxamer Sales by Application (2021-2026) & (Tons) Table 107. North America Poloxamer Sales by Application (2027-2032) & (Tons) Table 108. North America Poloxamer Sales Price by Application (2021-2026) & (US$/Ton) Table 109. North America Poloxamer Sales Price by Application (2027-2032) & (US$/Ton) Table 110. North America Poloxamer Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. North America Poloxamer Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 112. North America Poloxamer Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 113. North America Poloxamer Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 114. North America Poloxamer Sales by Country (2021-2026) & (Tons) Table 115. North America Poloxamer Sales by Country (2027-2032) & (Tons) Table 116. North America Poloxamer Sales Price by Country (2021-2026) & (US$/Ton) Table 117. North America Poloxamer Sales Price by Country (2027-2032) & (US$/Ton) Table 118. United States Poloxamer Revenue (2021-2032) & (US$ Million) Table 119. Canada Poloxamer Revenue (2021-2032) & (US$ Million) Table 120. Poloxamer Revenue (2021-2032) & (US$ Million) Table 121. Europe Poloxamer Revenue by Type (2021-2026) & (US$ Million) Table 122. Europe Poloxamer Revenue by Type (2027-2032) & (US$ Million) Table 123. Europe Poloxamer Sales by Type (2021-2026) & (Tons) Table 124. Europe Poloxamer Sales by Type (2027-2032) & (Tons) Table 125. Europe Poloxamer Sales Price by Type (2021-2026) & (US$/Ton) Table 126. Europe Poloxamer Sales Price by Type (2027-2032) & (US$/Ton) Table 127. Europe Poloxamer Revenue by Application (2021-2026) & (US$ Million) Table 128. Europe Poloxamer Revenue by Application (2027-2032) & (US$ Million) Table 129. Europe Poloxamer Sales by Application (2021-2026) & (Tons) Table 130. Europe Poloxamer Sales by Application (2027-2032) & (Tons) Table 131. Europe Poloxamer Sales Price by Application (2021-2026) & (US$/Ton) Table 132. Europe Poloxamer Sales Price by Application (2027-2032) & (US$/Ton) Table 133. Europe Poloxamer Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Europe Poloxamer Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 135. Europe Poloxamer Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 136. Europe Poloxamer Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 137. Europe Poloxamer Sales by Country (2021-2026) & (Tons) Table 138. Europe Poloxamer Sales by Country (2027-2032) & (Tons) Table 139. Europe Poloxamer Sales Price by Country (2021-2026) & (US$/Ton) Table 140. Europe Poloxamer Sales Price by Country (2027-2032) & (US$/Ton) Table 141. Germany Poloxamer Revenue (2021-2032) & (US$ Million) Table 142. France Poloxamer Revenue (2021-2032) & (US$ Million) Table 143. U.K. Poloxamer Revenue (2021-2032) & (US$ Million) Table 144. Italy Poloxamer Revenue (2021-2032) & (US$ Million) Table 145. Netherlands Poloxamer Revenue (2021-2032) & (US$ Million) Table 146. China Poloxamer Revenue by Type (2021-2026) & (US$ Million) Table 147. China Poloxamer Revenue by Type (2027-2032) & (US$ Million) Table 148. China Poloxamer Sales by Type (2021-2026) & (Tons) Table 149. China Poloxamer Sales by Type (2027-2032) & (Tons) Table 150. China Poloxamer Sales Price by Type (2021-2026) & (US$/Ton) Table 151. China Poloxamer Sales Price by Type (2027-2032) & (US$/Ton) Table 152. China Poloxamer Revenue by Application (2021-2026) & (US$ Million) Table 153. China Poloxamer Revenue by Application (2027-2032) & (US$ Million) Table 154. China Poloxamer Sales by Application (2021-2026) & (Tons) Table 155. China Poloxamer Sales by Application (2027-2032) & (Tons) Table 156. China Poloxamer Sales Price by Application (2021-2026) & (US$/Ton) Table 157. China Poloxamer Sales Price by Application (2027-2032) & (US$/Ton) Table 158. Asia Poloxamer Revenue by Type (2021-2026) & (US$ Million) Table 159. Asia Poloxamer Revenue by Type (2027-2032) & (US$ Million) Table 160. Asia Poloxamer Sales by Type (2021-2026) & (Tons) Table 161. Asia Poloxamer Sales by Type (2027-2032) & (Tons) Table 162. Asia Poloxamer Sales Price by Type (2021-2026) & (US$/Ton) Table 163. Asia Poloxamer Sales Price by Type (2027-2032) & (US$/Ton) Table 164. Asia Poloxamer Revenue by Application (2021-2026) & (US$ Million) Table 165. Asia Poloxamer Revenue by Application (2027-2032) & (US$ Million) Table 166. Asia Poloxamer Sales by Application (2021-2026) & (Tons) Table 167. Asia Poloxamer Sales by Application (2027-2032) & (Tons) Table 168. Asia Poloxamer Sales Price by Application (2021-2026) & (US$/Ton) Table 169. Asia Poloxamer Sales Price by Application (2027-2032) & (US$/Ton) Table 170. Asia Poloxamer Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. Asia Poloxamer Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. Asia Poloxamer Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. Asia Poloxamer Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 174. Asia Poloxamer Sales by Country (2021-2026) & (Tons) Table 175. Asia Poloxamer Sales by Country (2027-2032) & (Tons) Table 176. Asia Poloxamer Sales Price by Country (2021-2026) & (US$/Ton) Table 177. Asia Poloxamer Sales Price by Country (2027-2032) & (US$/Ton) Table 178. Japan Poloxamer Revenue (2021-2032) & (US$ Million) Table 179. South Korea Poloxamer Revenue (2021-2032) & (US$ Million) Table 180. India Poloxamer Revenue (2021-2032) & (US$ Million) Table 181. Australia Poloxamer Revenue (2021-2032) & (US$ Million) Table 182. China Taiwan Poloxamer Revenue (2021-2032) & (US$ Million) Table 183. Southeast Asia Poloxamer Revenue (2021-2032) & (US$ Million) Table 184. SAMEA Poloxamer Revenue by Type (2021-2026) & (US$ Million) Table 185. SAMEA Poloxamer Revenue by Type (2027-2032) & (US$ Million) Table 186. SAMEA Poloxamer Sales by Type (2021-2026) & (Tons) Table 187. SAMEA Poloxamer Sales by Type (2027-2032) & (Tons) Table 188. SAMEA Poloxamer Sales Price by Type (2021-2026) & (US$/Ton) Table 189. SAMEA Poloxamer Sales Price by Type (2027-2032) & (US$/Ton) Table 190. SAMEA Poloxamer Revenue by Application (2021-2026) & (US$ Million) Table 191. SAMEA Poloxamer Revenue by Application (2027-2032) & (US$ Million) Table 192. SAMEA Poloxamer Sales by Application (2021-2026) & (Tons) Table 193. SAMEA Poloxamer Sales by Application (2027-2032) & (Tons) Table 194. SAMEA Poloxamer Sales Price by Application (2021-2026) & (US$/Ton) Table 195. SAMEA Poloxamer Sales Price by Application (2027-2032) & (US$/Ton) Table 196. SAMEA Poloxamer Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 197. SAMEA Poloxamer Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 198. SAMEA Poloxamer Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 199. SAMEA Poloxamer Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 200. SAMEA Poloxamer Sales by Country (2021-2026) & (Tons) Table 201. SAMEA Poloxamer Sales by Country (2027-2032) & (Tons) Table 202. SAMEA Poloxamer Sales Price by Country (2021-2026) & (US$/Ton) Table 203. SAMEA Poloxamer Sales Price by Country (2027-2032) & (US$/Ton) Table 204. Brazil Poloxamer Revenue (2021-2032) & (US$ Million) Table 205. Argentina Poloxamer Revenue (2021-2032) & (US$ Million) Table 206. Chile Poloxamer Revenue (2021-2032) & (US$ Million) Table 207. Colombia Poloxamer Revenue (2021-2032) & (US$ Million) Table 208. Peru Poloxamer Revenue (2021-2032) & (US$ Million) Table 209. Saudi Arabia Poloxamer Revenue (2021-2032) & (US$ Million) Table 210. Israel Poloxamer Revenue (2021-2032) & (US$ Million) Table 211. UAE Poloxamer Revenue (2021-2032) & (US$ Million) Table 212. Turkey Poloxamer Revenue (2021-2032) & (US$ Million) Table 213. Iran Poloxamer Revenue (2021-2032) & (US$ Million) Table 214. Egypt Poloxamer Revenue (2021-2032) & (US$ Million) Table 215. Key Raw Materials Table 216. Raw Materials Key Suppliers Table 217. Poloxamer Distributors List Table 218. Poloxamer Customers List Table 219. Research Programs/Design for This Report Table 220. Authors List of This Report Table 221. Secondary Sources Table 222. Primary Sources List of Figures Figure 1. Poloxamer Product Image Figure 2. Global Poloxamer Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Poloxamer Market Size Share 2021 VS 2025 VS 2032 Figure . Poloxamer 124 Image Figure 1. Poloxamer 184 Image Figure 2. Poloxamer 188 Image Figure 3. Poloxamer 338 Image Figure 4. Poloxamer 407 Image Figure 5. Others Image Figure 6. Global Poloxamer Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Poloxamer Market Size Share 2021 VS 2025 VS 2032 Figure 8. Cosmetics Industrial Image Figure 9. Biologics Image Figure 10. Pharmaceutical Industrial Image Figure 11. Others Image Figure 12. Global Poloxamer Capacity, Capacity Utilization (2021-2032) & (Tons) Figure 13. Global Poloxamer Production by Region: 2021 VS 2025 VS 2032 (Tons) Figure 14. Global Poloxamer Production Market Share by Region: 2025 Versus 2032 Figure 15. Global Poloxamer Production Market Share by Region (2021-2032) Figure 16. North America Poloxamer Production Growth Rate (2021-2032) & (Tons) Figure 17. Europe Poloxamer Production Growth Rate (2021-2032) & (Tons) Figure 18. China Poloxamer Production Growth Rate (2021-2032) & (Tons) Figure 19. Japan Poloxamer Production Growth Rate (2021-2032) & (Tons) Figure 20. Global Poloxamer Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 21. Global Poloxamer Revenue (2021-2032) & (US$ Million) Figure 22. Global Poloxamer Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Poloxamer Revenue Market Share by Region: 2025 Versus 2032 Figure 24. Global Poloxamer Revenue Market Share by Region (2021-2032) Figure 25. Global Poloxamer Sales (2021-2032) & (Tons) Figure 26. Global Poloxamer Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 27. Global Poloxamer Sales Market Share by Region (2021-2032) Figure 28. North America Poloxamer Sales YoY (2021-2032) & (Tons) Figure 29. Europe Poloxamer Sales YoY (2021-2032) & (Tons) Figure 30. China Poloxamer Sales YoY (2021-2032) & (Tons) Figure 31. Asia (Excluding China) Poloxamer Sales YoY (2021-2032) & (Tons) Figure 32. South America, Middle East and Africa Poloxamer Sales YoY (2021-2032) & (Tons) Figure 33. Global Poloxamer Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 34. Global Poloxamer Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 35. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 36. Global Poloxamer Revenue Market Share by Type (2021-2032) Figure 37. Global Poloxamer Sales Market Share by Type (2021-2032) Figure 38. Global Poloxamer Revenue Market Share by Application (2021-2032) Figure 39. Global Poloxamer Sales Market Share by Application (2021-2032) Figure 40. North America Poloxamer Revenue Share by Type (2021-2032) Figure 41. North America Poloxamer Sales Share by Type (2021-2032) Figure 42. North America Poloxamer Revenue Share by Application (2021-2032) Figure 43. North America Poloxamer Sales Share by Application (2021-2032) Figure 44. North America Poloxamer Revenue Share by Country (2021-2032) Figure 45. North America Poloxamer Sales Share by Country (2021-2032) Figure 46. Europe Poloxamer Revenue Share by Type (2021-2032) Figure 47. Europe Poloxamer Sales Share by Type (2021-2032) Figure 48. Europe Poloxamer Revenue Share by Application (2021-2032) Figure 49. Europe Poloxamer Sales Share by Application (2021-2032) Figure 50. Europe Poloxamer Revenue Share by Country (2021-2032) Figure 51. Europe Poloxamer Sales Share by Country (2021-2032) Figure 52. China Poloxamer Revenue Share by Type (2021-2032) Figure 53. China Poloxamer Sales Share by Type (2021-2032) Figure 54. China Poloxamer Revenue Share by Application (2021-2032) Figure 55. China Poloxamer Sales Share by Application (2021-2032) Figure 56. Asia Poloxamer Revenue Share by Type (2021-2032) Figure 57. Asia Poloxamer Sales Share by Type (2021-2032) Figure 58. Asia Poloxamer Revenue Share by Application (2021-2032) Figure 59. Asia Poloxamer Sales Share by Application (2021-2032) Figure 60. Asia Poloxamer Revenue Share by Country (2021-2032) Figure 61. Asia Poloxamer Sales Share by Country (2021-2032) Figure 62. SAMEA Poloxamer Revenue Share by Type (2021-2032) Figure 63. SAMEA Poloxamer Sales Share by Type (2021-2032) Figure 64. SAMEA Poloxamer Revenue Share by Application (2021-2032) Figure 65. SAMEA Poloxamer Sales Share by Application (2021-2032) Figure 66. SAMEA Poloxamer Revenue Share by Country (2021-2032) Figure 67. SAMEA Poloxamer Sales Share by Country (2021-2032) Figure 68. Poloxamer Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Poloxamer Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Poloxamer 124
  • Poloxamer 184
  • Poloxamer 188
  • Poloxamer 338
  • Poloxamer 407
  • Others
Applications
  • Cosmetics Industrial
  • Biologics
  • Pharmaceutical Industrial
  • Others
Companies covered
  • BASF
  • ADEKA
  • Croda
  • Nanjing Well
  • Hubei Hengshuo
  • Solvay
  • Merck KGaA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Poloxamer Market by Type
  3. 1.2.1 Global Poloxamer Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Poloxamer 124
  5. 1.2.3 Poloxamer 184
  6. 1.2.4 Poloxamer 188
  7. 1.2.5 Poloxamer 338
  8. 1.2.6 Poloxamer 407
  9. 1.2.7 Others
  10. 1.3 Poloxamer Market by Application
  11. 1.3.1 Global Poloxamer Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Cosmetics Industrial
  13. 1.3.3 Biologics
  14. 1.3.4 Pharmaceutical Industrial
  15. 1.3.5 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Poloxamer Market Dynamics
  1. 2.1 Poloxamer Industry Trends
  2. 2.2 Poloxamer Industry Drivers
  3. 2.3 Poloxamer Industry Opportunities and Challenges
  4. 2.4 Poloxamer Industry Restraints
3 Global Poloxamer Production Overview
  1. 3.1 Global Poloxamer Production Capacity (2021-2032)
  2. 3.2 Global Poloxamer Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global Poloxamer Production by Region
  4. 3.3.1 Global Poloxamer Production by Region (2021-2026)
  5. 3.3.2 Global Poloxamer Production by Region (2027-2032)
  6. 3.3.3 Global Poloxamer Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
4 Global Market Growth Prospects
  1. 4.1 Global Poloxamer Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global Poloxamer Revenue by Region
  3. 4.2.1 Global Poloxamer Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global Poloxamer Revenue by Region (2021-2026)
  5. 4.2.3 Global Poloxamer Revenue by Region (2027-2032)
  6. 4.2.4 Global Poloxamer Revenue Market Share by Region (2021-2032)
  7. 4.3 Global Poloxamer Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global Poloxamer Sales by Region
  9. 4.4.1 Global Poloxamer Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global Poloxamer Sales by Region (2021-2026)
  11. 4.4.3 Global Poloxamer Sales by Region (2027-2032)
  12. 4.4.4 Global Poloxamer Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global Poloxamer Revenue by Manufacturers
  2. 5.1.1 Global Poloxamer Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global Poloxamer Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global Poloxamer Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global Poloxamer Sales by Manufacturers
  6. 5.2.1 Global Poloxamer Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global Poloxamer Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global Poloxamer Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global Poloxamer Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global Poloxamer Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global Poloxamer Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global Poloxamer Manufacturers, Product Type & Application
  13. 5.7 Global Poloxamer Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global Poloxamer Market CR5 and HHI
  16. 5.8.2 2025 Poloxamer Tier 1, Tier 2, and Tier 3
6 Poloxamer Market by Type
  1. 6.1 Global Poloxamer Revenue by Type
  2. 6.1.1 Global Poloxamer Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global Poloxamer Revenue Market Share by Type (2021-2032)
  4. 6.2 Global Poloxamer Sales by Type
  5. 6.2.1 Global Poloxamer Sales by Type (2021-2032) & (Tons)
  6. 6.2.2 Global Poloxamer Sales Market Share by Type (2021-2032)
  7. 6.3 Global Poloxamer Price by Type
7 Poloxamer Market by Application
  1. 7.1 Global Poloxamer Revenue by Application
  2. 7.1.1 Global Poloxamer Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global Poloxamer Revenue Market Share by Application (2021-2032)
  4. 7.2 Global Poloxamer Sales by Application
  5. 7.2.1 Global Poloxamer Sales by Application (2021-2032) & (Tons)
  6. 7.2.2 Global Poloxamer Sales Market Share by Application (2021-2032)
  7. 7.3 Global Poloxamer Price by Application
8 Company Profiles
  1. 8.1 BASF
  2. 8.1.1 BASF Company Information
  3. 8.1.2 BASF Business Overview
  4. 8.1.3 BASF Poloxamer Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 BASF Poloxamer Product Portfolio
  6. 8.1.5 BASF Recent Developments
  7. 8.2 ADEKA
  8. 8.2.1 ADEKA Company Information
  9. 8.2.2 ADEKA Business Overview
  10. 8.2.3 ADEKA Poloxamer Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 ADEKA Poloxamer Product Portfolio
  12. 8.2.5 ADEKA Recent Developments
  13. 8.3 Croda
  14. 8.3.1 Croda Company Information
  15. 8.3.2 Croda Business Overview
  16. 8.3.3 Croda Poloxamer Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 Croda Poloxamer Product Portfolio
  18. 8.3.5 Croda Recent Developments
  19. 8.4 Nanjing Well
  20. 8.4.1 Nanjing Well Company Information
  21. 8.4.2 Nanjing Well Business Overview
  22. 8.4.3 Nanjing Well Poloxamer Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 8.4.4 Nanjing Well Poloxamer Product Portfolio
  24. 8.4.5 Nanjing Well Recent Developments
  25. 8.5 Hubei Hengshuo
  26. 8.5.1 Hubei Hengshuo Company Information
  27. 8.5.2 Hubei Hengshuo Business Overview
  28. 8.5.3 Hubei Hengshuo Poloxamer Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 8.5.4 Hubei Hengshuo Poloxamer Product Portfolio
  30. 8.5.5 Hubei Hengshuo Recent Developments
  31. 8.6 Solvay
  32. 8.6.1 Solvay Company Information
  33. 8.6.2 Solvay Business Overview
  34. 8.6.3 Solvay Poloxamer Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 8.6.4 Solvay Poloxamer Product Portfolio
  36. 8.6.5 Solvay Recent Developments
  37. 8.7 Merck KGaA
  38. 8.7.1 Merck KGaA Company Information
  39. 8.7.2 Merck KGaA Business Overview
  40. 8.7.3 Merck KGaA Poloxamer Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 8.7.4 Merck KGaA Poloxamer Product Portfolio
  42. 8.7.5 Merck KGaA Recent Developments
9 North America
  1. 9.1 North America Poloxamer Market Size by Type
  2. 9.1.1 North America Poloxamer Revenue by Type (2021-2032)
  3. 9.1.2 North America Poloxamer Sales by Type (2021-2032)
  4. 9.1.3 North America Poloxamer Price by Type (2021-2032)
  5. 9.2 North America Poloxamer Market Size by Application
  6. 9.2.1 North America Poloxamer Revenue by Application (2021-2032)
  7. 9.2.2 North America Poloxamer Sales by Application (2021-2032)
  8. 9.2.3 North America Poloxamer Price by Application (2021-2032)
  9. 9.3 North America Poloxamer Market Size by Country
  10. 9.3.1 North America Poloxamer Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America Poloxamer Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America Poloxamer Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
10 Europe
  1. 10.1 Europe Poloxamer Market Size by Type
  2. 10.1.1 Europe Poloxamer Revenue by Type (2021-2032)
  3. 10.1.2 Europe Poloxamer Sales by Type (2021-2032)
  4. 10.1.3 Europe Poloxamer Price by Type (2021-2032)
  5. 10.2 Europe Poloxamer Market Size by Application
  6. 10.2.1 Europe Poloxamer Revenue by Application (2021-2032)
  7. 10.2.2 Europe Poloxamer Sales by Application (2021-2032)
  8. 10.2.3 Europe Poloxamer Price by Application (2021-2032)
  9. 10.3 Europe Poloxamer Market Size by Country
  10. 10.3.1 Europe Poloxamer Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe Poloxamer Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe Poloxamer Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Netherlands
11 China
  1. 11.1 China Poloxamer Market Size by Type
  2. 11.1.1 China Poloxamer Revenue by Type (2021-2032)
  3. 11.1.2 China Poloxamer Sales by Type (2021-2032)
  4. 11.1.3 China Poloxamer Price by Type (2021-2032)
  5. 11.2 China Poloxamer Market Size by Application
  6. 11.2.1 China Poloxamer Revenue by Application (2021-2032)
  7. 11.2.2 China Poloxamer Sales by Application (2021-2032)
  8. 11.2.3 China Poloxamer Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia Poloxamer Market Size by Type
  2. 12.1.1 Asia Poloxamer Revenue by Type (2021-2032)
  3. 12.1.2 Asia Poloxamer Sales by Type (2021-2032)
  4. 12.1.3 Asia Poloxamer Price by Type (2021-2032)
  5. 12.2 Asia Poloxamer Market Size by Application
  6. 12.2.1 Asia Poloxamer Revenue by Application (2021-2032)
  7. 12.2.2 Asia Poloxamer Sales by Application (2021-2032)
  8. 12.2.3 Asia Poloxamer Price by Application (2021-2032)
  9. 12.3 Asia Poloxamer Market Size by Country
  10. 12.3.1 Asia Poloxamer Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia Poloxamer Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia Poloxamer Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA Poloxamer Market Size by Type
  2. 13.1.1 SAMEA Poloxamer Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA Poloxamer Sales by Type (2021-2032)
  4. 13.1.3 SAMEA Poloxamer Price by Type (2021-2032)
  5. 13.2 SAMEA Poloxamer Market Size by Application
  6. 13.2.1 SAMEA Poloxamer Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA Poloxamer Sales by Application (2021-2032)
  8. 13.2.3 SAMEA Poloxamer Price by Application (2021-2032)
  9. 13.3 SAMEA Poloxamer Market Size by Country
  10. 13.3.1 SAMEA Poloxamer Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA Poloxamer Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA Poloxamer Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 Poloxamer Value Chain Analysis
  2. 14.1.1 Poloxamer Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 Poloxamer Production Mode & Process
  6. 14.2 Poloxamer Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 Poloxamer Distributors
  9. 14.2.3 Poloxamer Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.